Low-dose esketamine administered post-labor significantly reduced depressive symptoms in women with prenatal depression within 42 days, despite an increase in short-lived neuropsychiatric side effects.
Inside the Alzheimer’s Association: Dr. Heather Snyder on Driving Research and Collaboration
Heather Snyder discusses the Alzheimer’s Association’s research initiatives, breakthroughs in diagnostics, and the importance of collaboration in dementia care.
October 28, 2024